Evidence map›Paper›PMID 16230999›Full record

ArticleBritish journal of pharmacology2005

Desensitization of neuronal nicotinic receptors of human neuroblastoma SH-SY5Y cells during short or long exposure to nicotine.

Elena Sokolova, Cosetta Matteoni, Andrea Nistri

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in British journal of pharmacology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Drug Discovery Targeting Nicotinic Acetylcholine Receptors for Hearing Loss.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  5. Review
  6. Article
  7. Article
  8. Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology.Methods in molecular biology (Clifton, N.J.) · 2013
    Article
  9. A single administration of low-dose varenicline saturates α4β2* nicotinic acetylcholine receptors in the human brain.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Article
  10. Article
  11. Article
  12. Article
  13. Cholinergic interneurons control the excitatory input to the striatum.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Elena SokolovaNeurobiology Sector, International School for Advanced Studies (SISSA), Via Beirut 4, Trieste 34014, Italy.
Cosetta Matteoni
Andrea Nistri
Scuola Internazionale Superiore di Studi Avanzati · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuronal nicotinic ACh receptors (nAChRs) readily desensitize in the presence of an agonist. However, when the agonist is applied for minutes, hours or days, it is unclear how extensive desensitization is, how long it persists after agonist removal and whether nAChRs consequently change their pharmacological properties. These issues were explored with electrophysiological studies of native receptors of voltage-clamped human neuroblastoma SH-SY5Y cells. Puffer pulses of nicotine (1 mM)-evoked inward currents partly antagonized by methyllycaconitine (MLA; 10 nM) or alpha-conotoxin MII (MII; 10 nM), suggesting contribution by alpha7 and alpha3 subunit containing receptors, respectively. Nicotine-evoked currents desensitized with 150 ms time constant and fully recovered after a few s washout. Although the current induced by 10 min application of nicotine (10 microM) decayed to baseline indicating complete desensitization, puffer applications of maximally effective doses of nicotine still generated small responses (22% of control). Similar responses to puffer-applied nicotine were observed when nicotine was chronically incubated for 8 or 48 h. On nicotine washout, cells recovered their response amplitude within 5 min and then increased it (about 50% of untreated controls) after 30 min without altering response kinetics or sensitivity to MLA and MII. The present results suggest that native nAChRs of SH-SY5Y cells preserved a degree of responsiveness during chronic application of nicotine, and that they rapidly recovered on washout to generate larger responses without changes in kinetics or pharmacology. These data indicate strong compensatory mechanisms to retain nicotinic receptor function during long-term exposure to nicotine.

Indexed as

Aconitinealpha7 Nicotinic Acetylcholine ReceptorCell Line, TumorConotoxinsDose-Response Relationship, DrugHumansKineticsMembrane PotentialsNeuroblastomaNeuronsNicotineNicotinic AgonistsNicotinic AntagonistsReceptors, NicotinicUp-RegulationAconitinealpha7 Nicotinic Acetylcholine ReceptorChrna7 protein, humanConotoxinsmethyllycaconitineNicotineNicotinic AgonistsNicotinic AntagonistsReceptors, Nicotinic

Identifiers

PMID16230999
PMCPMC1751247
OpenAlexW1897713076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.